What is Zone Labs?
Founded in 1995 by Dr. Barry Sears, Zone Labs operates at the intersection of nutritional science and chronic disease management. The company specializes in patented nutraceutical products designed to regulate diet-induced inflammation, a core pillar of Dr. Sears' research. By leveraging cutting-edge technology to produce dietary supplements, functional foods, and specialized skincare, Zone Labs has established itself as a global authority in wellness. Its international distribution network spans across Europe, Latin America, and Asia, reflecting a robust enterprise model that integrates clinical research with consumer-facing health solutions.
How much funding has Zone Labs raised?
Zone Labs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Zone Labs
PPP
Public-Private Partnership
What's next for Zone Labs?
With the recent influx of capital, Zone Labs is positioned to accelerate its research and development initiatives, further refining its evidence-based wellness portfolio. The strategic focus will likely shift toward deepening market penetration in existing international territories and optimizing supply chain efficiencies to meet the rising global demand for anti-inflammatory health products. As the company navigates this late-stage growth phase, the emphasis remains on maintaining scientific integrity while scaling its proprietary product lines to address the evolving needs of the health-conscious consumer demographic.
See full Zone Labs company page
